Associate Director of Marketing
Alnylam Pharmaceuticals
Associate Director of Marketing
Alnylam Pharmaceuticals
Develops RNAi-based therapies for genetic diseases
Overview
The Associate Director of Marketing, KOL Engagement and Enablement is responsible for leading strategic initiatives that enhance Key Opinion Leader (KOL) engagement, Thought Leader Liaison (TLL) effectiveness, and the optimization of actionable insights across the organization. This role serves as a strategic partner to TLLs, Marketing, Medical Affairs, Global, Legal, Compliance, and field leadership to advance engagement strategies, educational initiatives, advisory boards, and external stakeholder partnerships. The Associate Director will lead the development of scalable programs, resources, and processes that strengthen organizational effectiveness, support field execution, and ensure insights are effectively translated into business action. This role reports to the Director of Marketing, KOL Strategy.
Key Responsibilities
Qualifications
#LI-EW1 #LI-Remote
The pay range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).
Alnylam’s robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.
Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers
U.S. Pay Range 161500 - 218500 USD
Develops RNAi-based therapies for genetic diseases
Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.
Explore more opportunities at Alnylam Pharmaceuticals